Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans
- PMID: 24866852
- PMCID: PMC4209941
- DOI: 10.1111/bph.12789
Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans
Abstract
Eating disorders, such as anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorders (BED), are described as abnormal eating habits that usually involve insufficient or excessive food intake. Animal models have been developed that provide insight into certain aspects of eating disorders. Several drugs have been found efficacious in these animal models and some of them have eventually proven useful in the treatment of eating disorders. This review will cover the role of monoaminergic neurotransmitters in eating disorders and their pharmacological manipulations in animal models and humans. Dopamine, 5-HT (serotonin) and noradrenaline in hypothalamic and striatal regions regulate food intake by affecting hunger and satiety and by affecting rewarding and motivational aspects of feeding. Reduced neurotransmission by dopamine, 5-HT and noradrenaline and compensatory changes, at least in dopamine D2 and 5-HT(2C/2A) receptors, have been related to the pathophysiology of AN in humans and animal models. Also, in disorders and animal models of BN and BED, monoaminergic neurotransmission is down-regulated but receptor level changes are different from those seen in AN. A hypofunctional dopamine system or overactive α2-adrenoceptors may contribute to an attenuated response to (palatable) food and result in hedonic binge eating. Evidence for the efficacy of monoaminergic treatments for AN is limited, while more support exists for the treatment of BN or BED with monoaminergic drugs.
© 2014 The British Pharmacological Society.
Figures

Similar articles
-
Hedonic hunger and binge eating among women with eating disorders.Int J Eat Disord. 2014 Apr;47(3):273-80. doi: 10.1002/eat.22171. Epub 2013 Sep 6. Int J Eat Disord. 2014. PMID: 24014479
-
[Triggers of bulimia and compulsion attacks: validation of the "Start" questionnaire].Encephale. 2014 Sep;40(4):323-9. doi: 10.1016/j.encep.2013.06.008. Epub 2013 Oct 1. Encephale. 2014. PMID: 24091068 French.
-
Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa.Neuropharmacology. 2012 Jul;63(1):87-96. doi: 10.1016/j.neuropharm.2011.11.010. Epub 2011 Nov 27. Neuropharmacology. 2012. PMID: 22138162 Free PMC article. Review.
-
Psychopharmacological advances in eating disorders.Expert Rev Clin Pharmacol. 2018 Jan;11(1):95-108. doi: 10.1080/17512433.2018.1383895. Epub 2017 Oct 5. Expert Rev Clin Pharmacol. 2018. PMID: 28933969 Review.
-
Dietary Restriction Behaviors and Binge Eating in Anorexia Nervosa, Bulimia Nervosa and Binge Eating Disorder: Trans-diagnostic Examination of the Restraint Model.Eat Behav. 2015 Aug;18:192-6. doi: 10.1016/j.eatbeh.2015.05.012. Epub 2015 Jun 10. Eat Behav. 2015. PMID: 26122390 Free PMC article.
Cited by
-
The Alpha-1 Adrenergic Receptor Antagonist Prazosin Reduces Binge-Like Eating in Rats.Nutrients. 2020 May 28;12(6):1569. doi: 10.3390/nu12061569. Nutrients. 2020. PMID: 32481494 Free PMC article.
-
Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior.Curr Neuropharmacol. 2016;14(2):118-42. doi: 10.2174/1570159x14666151109103147. Curr Neuropharmacol. 2016. PMID: 26549651 Free PMC article. Review.
-
Acute and long-lasting effects of adolescent fluoxetine exposure on feeding behavior in Sprague-Dawley rats.Dev Psychobiol. 2022 Dec;64(8):e22345. doi: 10.1002/dev.22345. Dev Psychobiol. 2022. PMID: 36426786 Free PMC article.
-
Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.CNS Drugs. 2019 Jan;33(1):31-46. doi: 10.1007/s40263-018-0594-5. CNS Drugs. 2019. PMID: 30523523 Review.
-
Emotional Eating, Binge Eating and Animal Models of Binge-Type Eating Disorders.Curr Obes Rep. 2017 Jun;6(2):217-228. doi: 10.1007/s13679-017-0265-8. Curr Obes Rep. 2017. PMID: 28434108 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources